Financing a life sciences startup is a complicated endeavor: the science is expensive, the timelines are long, and investors need to have a strong stomach.
Read MoreLiquid alternative investments offer an increasingly compelling diversification strategy in a time of great economic uncertainty.
Read MoreBaby Boomers are looking for alternative sources of income as they retire, and real estate crowdfunding provides an opportunity to passively invest.
Read MoreCommercial litigation finance has grown from a niche concept into a mainstream financial tool for businesses and law firms.
Read MoreThe life sciences industry is one of the economy’s most complex with a unique rhythm, risk profile, and regulatory framework.
Read MoreSince the SEC lifted a ban on general solicitation, investors can find deals through hedge fund platforms online. But caveat emptor!
Read MoreAngel investors are wealthy individuals who invest in promising startups, but more than money, angel investing requires business savvy and good judgment.
Read MorePrivate equity investor satisfaction has shifted in response to macroeconomic pressures and market volatility. Explore PE in 2025 and what’s driving expectations for future returns.
Read MoreBuilding a collection of rare coins can be a fun way to diversify your investment portfolio particularly in a climate of economic uncertainty.
Read MorePrivate equity may be on the road to recovery, but the growing backlog of PE-backed companies awaiting exits remains a challenge for investors.
Read More